Loading insider details...
Beta
Latest Form 4 (Jun 29, 2026): Grant/Award of 29,888 ERAS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 29, 2026 | Erasca, Inc. (ERAS) | Grant/Award | 29,888 | n/a |
| Jan 6, 2026 | Oric Pharmaceuticals, Inc. (ORIC) | Grant/Award | 214,000 | n/a |
| Jan 5, 2026 | Erasca, Inc. (ERAS) | Grant/Award | 19,532 | n/a |
| Dec 17, 2025 | Oric Pharmaceuticals, Inc. (ORIC) | Exercise/Conversion | 29,333 | n/a |
| Jun 26, 2025 | Erasca, Inc. (ERAS) | Grant/Award | 120,000 | n/a |
| Jun 3, 2025 | Erasca, Inc. (ERAS) | Gift | 6,200 | n/a |
| Jan 3, 2025 | Oric Pharmaceuticals, Inc. (ORIC) | Grant/Award | 202,500 | n/a |
| Dec 17, 2024 | Oric Pharmaceuticals, Inc. (ORIC) | Exercise/Conversion | 24,042 | n/a |
| Jun 21, 2024 | Erasca, Inc. (ERAS) | Grant/Award | 60,000 | n/a |
| Jun 21, 2024 | CHIMERIX INC (CMRX) | Grant/Award | 60,000 | n/a |